sophiagenetics.com - היקף נכסי החברה SOPH

SOPHiA GENETICS SA (SOPH) is developing a cloud-based AI toolkit for genetic analysis and cancer combat, leveraging a unique patient dataset and extensive clinical integration. The business's success is based on the global growth of genetic testing and strict adherence to data privacy. The company's total assets amount to 188.01, which is clearly demonstrated by the price action on the GURU.Markets platform.

This indicator reflects the market value of all corporate resources, providing a real-time assessment of profit generation potential. By analyzing fluctuations in property and resources, an investor can track asset capitalization dynamics via a reverse return on assets (ROA) calculation. The metric is highly sensitive to exchange quotes, necessitating caution when interpreting sharp spikes. For SOPHiA GENETICS SA (SOPH), this confirms the effectiveness of cost optimization amid steady demand for genomic IT solutions.